BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17623077)

  • 1. Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT.
    Boers KE; Bijlenga D; Mol BW; LeCessie S; Birnie E; van Pampus MG; Stigter RH; Bloemenkamp KW; van Meir CA; van der Post JA; Bekedam DJ; Ribbert LS; Drogtrop AP; van der Salm PC; Huisjes AJ; Willekes C; Roumen FJ; Scheepers HC; de Boer K; Duvekot JJ; Thornton JG; Scherjon SA
    BMC Pregnancy Childbirth; 2007 Jul; 7():12. PubMed ID: 17623077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial).
    Vijgen SM; Boers KE; Opmeer BC; Bijlenga D; Bekedam DJ; Bloemenkamp KW; de Boer K; Bremer HA; le Cessie S; Delemarre FM; Duvekot JJ; Hasaart TH; Kwee A; van Lith JM; van Meir CA; van Pampus MG; van der Post JA; Rijken M; Roumen FJ; van der Salm PC; Spaanderman ME; Willekes C; Wijnen EJ; Mol BW; Scherjon SA
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):358-63. PubMed ID: 23910171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
    Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW;
    BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial.
    Tajik P; van Wyk L; Boers KE; le Cessie S; Zafarmand MH; Roumen F; van der Post JA; Porath M; van Pampus MG; Spaanderdam ME; Kwee A; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; van Lith JM; Bossuyt PM; Mol BW; Scherjon SA;
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():20-5. PubMed ID: 24192662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.
    Koopmans CM; Bijlenga D; Aarnoudse JG; van Beek E; Bekedam DJ; van den Berg PP; Burggraaff JM; Birnie E; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; le Cessie S; van Loon AJ; Mol BW; van der Post JA; Roumen FJ; Scheepers HC; Spaanderman ME; Stigter RH; Willekes C; van Pampus MG
    BMC Pregnancy Childbirth; 2007 Jul; 7():14. PubMed ID: 17662114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT).
    Boers KE; Vijgen SM; Bijlenga D; van der Post JA; Bekedam DJ; Kwee A; van der Salm PC; van Pampus MG; Spaanderman ME; de Boer K; Duvekot JJ; Bremer HA; Hasaart TH; Delemarre FM; Bloemenkamp KW; van Meir CA; Willekes C; Wijnen EJ; Rijken M; le Cessie S; Roumen FJ; Thornton JG; van Lith JM; Mol BW; Scherjon SA;
    BMJ; 2010 Dec; 341():c7087. PubMed ID: 21177352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial).
    van der Ham DP; Nijhuis JG; Mol BW; van Beek JJ; Opmeer BC; Bijlenga D; Groenewout M; Arabin B; Bloemenkamp KW; van Wijngaarden WJ; Wouters MG; Pernet PJ; Porath MM; Molkenboer JF; Derks JB; Kars MM; Scheepers HC; Weinans MJ; Woiski MD; Wildschut HI; Willekes C
    BMC Pregnancy Childbirth; 2007 Jul; 7():11. PubMed ID: 17617892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol of SWEPIS a Swedish multicentre register based randomised controlled trial to compare induction of labour at 41 completed gestational weeks versus expectant management and induction at 42 completed gestational weeks.
    Elden H; Hagberg H; Wessberg A; Sengpiel V; Herbst A; Bullarbo M; Bergh C; Bolin K; Malbasic S; Saltvedt S; Stephansson O; Wikström AK; Ladfors L; Wennerholm UB
    BMC Pregnancy Childbirth; 2016 Mar; 16():49. PubMed ID: 26951777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT.
    Boers KE; van Wyk L; van der Post JA; Kwee A; van Pampus MG; Spaanderdam ME; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; Rijken M; Roumen FJ; Thornton JG; van Lith JM; Mol BW; le Cessie S; Scherjon SA;
    Am J Obstet Gynecol; 2012 Apr; 206(4):344.e1-7. PubMed ID: 22342897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of induction of labour versus expectant management in women with impending post-term pregnancies: the 41 week - 42 week dilemma.
    Kortekaas JC; Bruinsma A; Keulen JK; van Dillen J; Oudijk MA; Zwart JJ; Bakker JJ; de Bont D; Nieuwenhuijze M; Offerhaus PM; van Kaam AH; Vandenbussche F; Mol BW; de Miranda E
    BMC Pregnancy Childbirth; 2014 Oct; 14():350. PubMed ID: 25338555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.
    Wennerholm UB; Saltvedt S; Wessberg A; Alkmark M; Bergh C; Wendel SB; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Wennergren G; Wikström AK; Elden H; Stephansson O; Hagberg H
    BMJ; 2019 Nov; 367():l6131. PubMed ID: 31748223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial.
    van Wyk L; Boers KE; van der Post JA; van Pampus MG; van Wassenaer AG; van Baar AL; Spaanderdam ME; Becker JH; Kwee A; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; Roumen FJ; van Lith JM; Mol BW; le Cessie S; Scherjon SA;
    Am J Obstet Gynecol; 2012 May; 206(5):406.e1-7. PubMed ID: 22444791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.
    Stock SJ; Bricker L; Norman JE; West HM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008968. PubMed ID: 27404120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of routine third trimester ultrasound screening for intrauterine growth restriction: study protocol of a nationwide stepped wedge cluster-randomized trial in The Netherlands (The IRIS Study).
    Henrichs J; Verfaille V; Viester L; Westerneng M; Molewijk B; Franx A; van der Horst H; Bosmans JE; de Jonge A; Jellema P;
    BMC Pregnancy Childbirth; 2016 Oct; 16(1):310. PubMed ID: 27737654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine growth restriction at term: induction or spontaneous labour? Disproportionate intrauterine growth intervention trial at term (DIGITAT): a pilot study.
    van den Hove MM; Willekes C; Roumen FJ; Scherjon SA
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):54-8. PubMed ID: 16054286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal health-related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeks.
    Bijlenga D; Boers KE; Birnie E; Mol BW; Vijgen SC; Van der Post JA; De Groot CJ; Rijnders RJ; Pernet PJ; Roumen FJ; Stigter RH; Delemarre FM; Bremer HA; Porath M; Scherjon SA; Bonsel GJ
    Qual Life Res; 2011 Nov; 20(9):1427-36. PubMed ID: 21468753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
    Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
    Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal and neonatal outcomes of elective induction of labor.
    Caughey AB; Sundaram V; Kaimal AJ; Cheng YW; Gienger A; Little SE; Lee JF; Wong L; Shaffer BL; Tran SH; Padula A; McDonald KM; Long EF; Owens DK; Bravata DM
    Evid Rep Technol Assess (Full Rep); 2009 Mar; (176):1-257. PubMed ID: 19408970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal death in a term fetal growth restriction randomized controlled trial: the paradox of prior risk and consent.
    van Wyk L; Boers KE; Gordijn SJ; Ganzevoort W; Bremer HA; Kwee A; Delemarre FMC; van Pampus MG; Bloemenkamp KWM; Roumen FJME; van Lith JMM; Mol BWJ; Thornton JG; Scherjon SA; le Cessie S;
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100239. PubMed ID: 33345938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.
    Bernardes TP; Broekhuijsen K; Koopmans CM; Boers KE; van Wyk L; Tajik P; van Pampus MG; Scherjon SA; Mol BW; Franssen MT; van den Berg PP; Groen H
    BJOG; 2016 Aug; 123(9):1501-8. PubMed ID: 27173131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.